High-mobility group box 1 and cancer. - Wikidata - awgldk - TriplyDB

High-mobility group box 1 and cancer.

High-mobility group box 1 and cancer.

http://www.wikidata.org/entity/Q33638306

about

Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process Endogenous HMGB1 regulates autophagy PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1 Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Clinical significance of procoagulant microparticles Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival Potential role of High mobility group box 1 in hepatocellular carcinoma Ménage à Trois in stress: DAMPs, redox and autophagy Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation.DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity Alarmins: awaiting a clinical response Integrating multi-platform genomic data using hierarchical Bayesian relevance vector machines Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet Trial HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells High mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell-cell adhesion.MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell.Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Expression of High-Mobility Group Box 1 Protein (HMGB1) and Toll-Like Receptor 9 (TLR9) in Retinas of Diabetic Rats Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas.HMGB1 release and redox regulates autophagy and apoptosis in cancer cells.A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway Diagnostic significance of serum HMGB1 in colorectal carcinomas Identification and characterization of the lamprey high-mobility group box 1 gene.High mobility group Box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression Zinc in innate and adaptive tumor immunity.The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.Molecular analysis of precursor lesions in familial pancreatic cancer HMGB1 in health and disease.Autophagy in immunity and cell-autonomous defense against intracellular microbes

P2860

Q21285160-6BC5DA3E-8688-49A4-94EF-A1DE778B4A3A Q24298865-520E43FF-D49A-4FE2-A3F4-F49CF47200C7 Q26738811-A5E79C48-9867-427D-92A9-AC4A1ACCA829 Q26768480-10F747DA-BB60-4E17-AB60-0E0CDF89B46A Q26774902-AB04E1A5-FB72-44C7-9789-3B10BE58C00D Q26781215-93971A0F-F94F-4594-A363-50BE95D21CCD Q26824613-23475610-3B31-4CAE-94AE-ED49C12EC671 Q26830846-DFCE2721-3991-4BF5-8A0C-834A140BB63E Q26853543-B79B3214-AD4C-4318-98B6-10A4951F492D Q26864508-2A25C332-891D-4539-9052-E88967E268DF Q27023542-AABB5888-9180-43B4-A0FA-A1D0B056AC85 Q28074543-D577523E-585E-49A0-AF83-B2873E6F9A54 Q28534956-DCA173C3-7FF9-4919-B0AD-98A1AEBD05C3 Q28611255-52AAC008-8BA2-438D-8481-78C2496C1141 Q30389531-C55EA9F3-C703-41C3-A319-05028AB7BB7C Q30499197-20229826-62EC-4A6B-83E2-B80ABB2A634A Q30523797-D0F0D2A7-805A-470B-B44D-8114B536017B Q30652069-8CF8CF9F-B894-43DB-B072-7D8ECB0A943B Q31010163-DA22AB0B-D4DD-4407-9519-628780F5086D Q33618428-F42B7AE1-3971-4F77-A527-AEE475448461 Q33689028-B085A9F7-CD4F-4150-986D-D1835F411475 Q33779216-780535A0-710B-4AF9-B61A-FF7594B7DA91 Q33831315-0E1ABE1A-726C-4181-A18F-E02D8601946D Q33853103-10836ABE-46A0-4A0F-A77F-AA755BAB325F Q33862088-6F5903CE-7CAE-4C89-976E-00FF1CBA10DC Q33874452-14C6E3D0-A5F5-4F72-A063-8B8C8F01D160 Q33881201-8410E12C-00E0-4F6B-8C4E-F4D717119196 Q33883123-E5B0E9AA-0F42-45B0-8BE0-39AF7380408E Q34019875-23C51BE4-404D-40E4-BFC4-D7BD5E0A7FC1 Q34154797-C490B926-AD20-4A74-8A77-CA4A9941B928 Q34179693-ECCDEE87-3926-4F42-9C08-D0856B6EBA4A Q34227734-31D3640E-8367-4B4D-80F3-477C9D309F65 Q34230026-B4E32A87-8B30-4331-83F3-201B754C944F Q34259728-4446134D-251D-49A5-A7F9-DB158AD2F697 Q34365721-B9C6A7FE-FD51-49D2-A790-46170CDFF0C2 Q34408184-AA89F77F-28E7-46A1-9412-EFC919ACD60E Q34428389-C263C895-A3AB-489A-AC65-FA3D929FBEE5 Q34571373-89C2FF34-81D8-479C-BA8A-670CF88D03D8 Q34622835-19F23D5D-1D6B-44E9-95BC-75D7DF193F8D Q34673845-8A3F3D4C-23C6-458D-9C33-B905788A5BA6

P2860

High-mobility group box 1 and cancer.

http://www.wikidata.org/entity/Q33638306

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

High-mobility group box 1 and cancer.

@ast

High-mobility group box 1 and cancer.

@en

type

label

High-mobility group box 1 and cancer.

@ast

High-mobility group box 1 and cancer.

@en

prefLabel

High-mobility group box 1 and cancer.

@ast

High-mobility group box 1 and cancer.

@en

P1433

Q33638306-EFDDA9DA-CE4B-43DC-A432-B4195552DE03

P1476

Q33638306-EF966460-DF6F-4868-A6D4-672E62D8EB3B

P2093

Q33638306-5F177F0E-53C9-4073-AEAD-5DB8777871B5

Q33638306-656A695D-FE9C-45CF-814D-E80536DC8F7E

Q33638306-77C094BF-FF8E-4701-8ED3-2ABA18580B50

Q33638306-CA9F2D3C-FED1-44AC-B36A-7D8B2D3B1ED2

P2860

Q33638306-049D3D4C-ECDD-4307-90A7-5F18D306A734

Q33638306-04D6F9C5-E8CD-4506-A75F-0E224B43D798

Q33638306-0951F169-831A-4767-B1A2-8A996048ED89

Q33638306-0B3BF679-26AD-4123-ADF6-A7D96FF7B3BD

Q33638306-12008311-4373-4CDC-A1DD-F7F575A48AE2

Q33638306-181AEB25-0FA2-409F-A523-A081E86BA2E3

Q33638306-18378764-3196-431F-9E9C-59BF33487208

Q33638306-19595DF3-3B00-46BF-A7AF-43C4FA957418

Q33638306-1B413D97-3591-40F2-BEDC-3F3B839F30BB

Q33638306-1C221BBF-1C44-421E-98DC-C387AAA94DA8

P304

Q33638306-1DAF4BA2-3A31-4497-A9D4-9590D4B18FC4

P31

Q33638306-03317F1F-18B9-4693-BD6A-5EA6311728C7

P356

Q33638306-036BF4D8-8728-4EC6-A0C5-5B748480C041

P407

Q33638306-049DBEBB-A353-4C2D-A0F2-036DBCCB489B

P433

Q33638306-B3AEB9AC-1BE2-45CC-9C43-FF2552CA77DC

P478

Q33638306-CF147EF9-3C21-48EA-98CB-5D4931619E9E

P577

Q33638306-52AC4458-4B6B-424E-8CCA-4BC3912404D6

P5875

Q33638306-763600B9-53AB-4F71-B371-56833E0AA573

P698

Q33638306-E0701911-209C-4E1C-862F-A094E0C4F4F6

P932

Q33638306-F845BABA-ADF2-44B0-848E-C2ECE91629E3

P356

J.BBAGRM.2009.11.014

P1433

Biochimica et Biophysica Acta

P1476

High-mobility group box 1 and cancer.

@en

P2093

Daolin Tang

http://www.w3.org/2001/XMLSchema#string

Herbert J Zeh

http://www.w3.org/2001/XMLSchema#string

Michael T Lotze

http://www.w3.org/2001/XMLSchema#string

Rui Kang

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins

High mobility group protein-1 (HMG-1) is a unique activator of p53

Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein

High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation

Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression

Damage associated molecular pattern molecules

Borna disease virus phosphoprotein represses p53-mediated transcriptional activity by interference with HMGB1

P304

131-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBAGRM.2009.11.014

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

1799

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41398310

http://www.w3.org/2001/XMLSchema#string

P698

20123075

http://www.w3.org/2001/XMLSchema#string

P932

2818552

http://www.w3.org/2001/XMLSchema#string